tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market
INKT
MiNK Therapeutics
RESEARCH TOOLSreports

MiNK Therapeutics (INKT) Income Statement

262 Followers

MiNK Therapeutics Income Statement

Last quarter (Q4 2025), MiNK Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, MiNK Therapeutics's net income was $-12.48B. See MiNK Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -181.75K$ -215.44K$ -204.62K$ -121.75K$ -77.96K
Operating Expenses
$ 12.31M$ 10.43M$ 22.72M$ 30.83M$ 18.53M
Depreciation and Amortization
$ 181.75K$ 215.44K$ 204.62K$ 121.75K$ 77.96K
EBITDA
$ -12.31M$ -10.57M$ -22.25M$ -27.87M$ -27.70M
Operating Income
$ -12.49M$ -10.65M$ -22.92M$ -30.95M$ -18.61M
Other Income/Expenses
$ -6.96K$ -134.56K$ 463.25K$ 2.96M$ -11.61M
Pretax Income
$ -12.49M$ -10.78M$ -22.46M$ -27.99M$ -30.21M
Net Income
$ -12.49B$ -10.78M$ -22.46M$ -27.99M$ -30.21M
Per Share Metrics
Basic EPS
$ -2.93$ -2.90$ -6.54$ -8.31$ -9.03
Diluted EPS
$ -2.93$ -2.80$ -6.54$ -8.31$ -9.03
Weighted Average Shares Outstanding
 4.27M 3.74M 3.44M 3.37M 3.35M
Weighted Average Shares Outstanding (Diluted)
 4.27M 3.86M 3.44M 3.37M 3.35M
Currency in USD

MiNK Therapeutics Earnings and Revenue History